indicalab.comAI-Powered Pathology - Indica Labs AI-Powered

Pathology HALO AP Dx Receives FDA 510(k) Clearance! Home Research Products Menu Toggle HALO | Quantitative Image Analysis for Pathology Menu Toggle HALO Modules HALO AI | Trainable AI for Pathology HALO Link | Collaborative Image Management for Pathology Clinical Products Menu Toggle HALO AP Dx | FDA-Cleared Diagnostics HALO AP® | AI Powered, Pathologist Driven HALO Clinical AI Menu Toggle HALO Prostate AI Breast IHC AI Lung PD-L1 AI SlideQC BF Services Menu Toggle Pharma Services Cloud Services About Menu ToggleNews and Events Partners Literature Contact Us Careers Support Menu Toggle Learning Portal Free Demo Free Demo Search for: Search Search HALO AP Dx Receives FDA 510(k) Clearance! Search for: Search SearchAI-Powered Pathology From discovery to diagnostics, AI powers our HALO software suite and services.Request a Live Demo Please enable JavaScript in your browser to complete this form. 1 Contact Info 2 Company/Region 3 Products & Services 4 Verify & Submit Form Name * First Last Email * Subscribe to receive news about webinars, software releases and more Subscribe to receive news about webinars, events, software releases and more. Next Company/Organization * Layout Country * Canada Canada United Kingdom United States of America Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia (Plurinational State of) Bonaire, Saint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo (Democratic Republic of the) Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czech Republic Côte d’Ivoire Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini (Kingdom of) Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland (Republic of) Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea (Democratic People’s Republic of) Korea (Republic of) Kosovo Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia (Federated States of) Moldova (Republic of) Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Macedonia (Republic of) Northern Mariana Islands Norway Oman Pakistan Palau Palestine (State of) Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Romania Russian Federation Rwanda Réunion Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Sweden Switzerland Syrian Arab Republic Taiwan, Republic of China Tajikistan Tanzania (United Republic of) Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkmenistan Turks and Caicos Islands Tuvalu Türkiye Uganda Ukraine United Arab Emirates United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican City State Venezuela (Bolivarian Republic of) Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Åland Islands Select State * Alabama Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Select Province * Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon Previous Next Products & Services * Research & Discovery Clinical and Diagnostic Services Select all that apply Layout Research & Discovery Products * HALO® HALO AI HALO Link Select all that apply Clinical and Diagnostic Products * FDA-Cleared HALO AP Dx HALO AP® Anatomic Pathology HALO Clinical AI Select all that apply HALO Clinical AI * HALO Prostate AI Breast IHC AI Lung PD-L1 AI SlideQC BF Select all that apply Services * Image Analysis or Pharma Services Cloud Services Select all that apply Additional Comments * Research & Discovery: HALO , HALO Link , HALO AI | Clinical & Diagnostic: HALO AP , HALO Clinical AI | Services: Cloud Services , Pharma Services Previous Next Submit Free Demo Transformative Digital Pathology Solutions​ Research & Discovery Clinical & Diagnostic Services Advance your pathology research with our AI-powered image analysis and collaborative image management platforms. ​ Accelerate your diagnoses with a comprehensive suite of tools for efficient image evaluation, management, and collaboration. ​ HALO AP Dx is a FDA-cleared case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology. HALO Clinical AI Solutions CE-IVD certified deep learning-based screening tool that assists pathologists in identification and grading of prostate cancer in core needle biopsies Automated, AI-based decision support tool to standardize scoring of PD-L1 IHC in non-small cell lung cancer Automated, AI-powered tool to standardize scoring of HER2, ER, PR, and Ki67 in primary invasive breast cancer Automated, AI-powered application for H&E-stained digitized slides that detects the most common artifacts Our AI-enabled services offering includes Pharma Services and AWS hosted HALO Cloud Services. Explore Our Integrated Platforms Learn how all of our HALO products fit together to offer an end-to-end digital pathology workflow from basic science research to clinical diagnostics! Want to Learn More? Indica Labs’ AI-Powered Pathology is Utilized in Labs Around the World Years of industry leading artificial intelligence 0 + Global deployments 0 + Deployments in all top 20 Pharma companies 0 /20 Peer-reviewed customer publications 0 + Employees in 12 countries 0 + What Our Customers & Partners Have to Say Indica Labs’ HALO is by far the most accurate, versatile, and user friendly digital image analysis platform that I have used. … HALO is a must have for any pathologist or scientist involved in quantifying immunohistochemical stains. In addition the HALO AI module is extremely easy to use. Within 20 minutes I was able to set up AI detection of tumor vs. normal tissue, as well as tumor epithelium vs stroma. HALO provides everything one needs for quantification of IHC for clinical and pre-clinical studies (of course with supervision of a pathologist). Best of all: it is fun, like a video game for Pathologists! Philip Martin Senior Pathologist, AstraZeneca Using HALO...